Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Coding Changes for 2007

Staff  |  Issue: March 2007  |  March 1, 2007

Note these CPT and Healthcare Common Procedure Coding System (HCPCS) code changes:

  • The previous CPT codes for dual energy X-ray absorptiometry and vertebral fracture assessment (codes 76075–76077) have been replaced by CPT codes 77080–77082.
  • Two common rheumatologic drugs have been given permanent HCPCS codes: J1740 for ibandronate sodium and J0129 for abatacept. Previously, these were coded as unlisted J3490 and J3590, respectively.
  • The HCPCS code J7319 will no longer code for the drugs Hyalgan, Supartz, Synvisc, Euflexxa, and Orthovisc.

CMS reversed the decision to combine these drugs under one code because of an October 2006 appeal by Genzyme, the manufacturer of Synvisc, a viscosupplement used to treat knee pain caused by osteoarthritis. Their argument was that reimbursement for Synvisc would be far below market value, discouraging doctors and patients from using it.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
click for large version

Because the J7319 decision was reversed after the 2007 HCPCS book was published, CMS has established four temporary Q-codes for the affected drugs for the rest of 2007:

These four new Q-codes are mandatory for billing CMS, but rheumatologists will need to ask private carriers if they are accepting the Q-codes.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Share: 

Filed under:Billing/CodingFrom the CollegePractice Support Tagged with:BillingCodingCPTMedicarePractice Managementrheumatologist

Related Articles
    Prepare NOW for ICD-10 Medical Coding Transition

    Prepare NOW for ICD-10 Medical Coding Transition

    July 14, 2015

    The ICD-10 page on the Centers for Medicare & Medicaid Services (CMS) website features a countdown clock that shows the time left until Oct. 1, 2015, the date on which compliance with the new code set becomes mandatory. By the time this issue goes to press, the clock will read 90 or fewer days. Time…

    The Anatomy of Coding

    June 13, 2011

    It is essential for coders to understand the rules of engagement, especially when it comes to correct coding and using the most up-to-date coding tools. Those who interact with Current Procedural Terminology (CPT), the International Classification of Diseases (ICD), or insurance companies also have the experience of dealing with the countless coding rules and guidelines.

    Steps to Help Rheumatologists Achieve Office Compliance in Laboratory Coding

    May 1, 2014

    A guide to ensure proper coding, billing and accurately diagnose patients.

    Key Facts on Billing Drug Wastage

    January 24, 2023

    The ACR has compiled guidelines and tips on how to use the JW modifier and correctly bill Medicare for discarded drugs and biologicals. This modifier can be applied only to unused amounts from a single-dose vial or package.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences